Since the device was not returned, it is impossible to proceed to actual evaluation.But, it is confirmed from the device history record that the suspected device had been manufactured with no significant issue and passed all the inspections.It is hard to find out exact root cause for this complaint, because it is difficult to reconstruct the situation at that time in the lab and limited info.On our user manual, it is mentioned that chemoradiation therapy or radiotherapy alone may lead to tumor shrinkage and subsequent stent migration.The pt died from subarachnoid hemorrhage, bleeding into the subarachnoid space.It is supposed that there is no relation to use of niti-s stent and pt's death.And there are no cses of subarachnoid hemorrhage in clinical evaluation report.We recognize the risk of stent migration, and have been conduced risk management.We will monitor this complaint occurrence for same model.This report is retrospective report due to fda foreign inspection warning letter.The suspected device is not registered to united states fda and it has been shipped into the united states.
|